SGK3 promotes estrogen receptor‐positive breast cancer proliferation by activating STAT3/ZMIZ2 pathway to stabilise β‐cateninLie Yuan, Weiying Zhou, Xu Liu et al.|British Journal of Pharmacology|2025Cited by 1